Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $6.99 Million - $8.7 Million
136,493 New
136,493 $8.27 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $195,078 - $240,070
3,740 New
3,740 $234,000
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $918,046 - $1.12 Million
13,072 New
13,072 $944,000
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $218,063 - $274,078
-3,295 Closed
0 $0
Q1 2022

May 18, 2022

BUY
$66.02 - $79.71 $217,535 - $262,644
3,295 New
3,295 $263,000
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $426,278 - $498,760
-6,730 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $74,369 - $90,993
1,083 Added 19.18%
6,730 $459,000
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $451,025 - $494,281
5,647 New
5,647 $475,000
Q1 2021

May 17, 2021

SELL
$76.02 - $100.5 $1.47 Million - $1.94 Million
-19,323 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$80.74 - $97.7 $1.12 Million - $1.35 Million
13,854 Added 253.32%
19,323 $1.68 Million
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $142,917 - $184,279
1,680 Added 44.34%
5,469 $491,000
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $239,453 - $351,626
-3,228 Reduced 46.0%
3,789 $394,000
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $443,334 - $603,251
7,017 New
7,017 $514,000
Q1 2020

May 14, 2020

SELL
$63.18 - $85.97 $169,891 - $231,173
-2,689 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $95,755 - $125,488
-1,311 Reduced 32.78%
2,689 $235,000
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $640,961 - $761,549
-8,802 Reduced 68.75%
4,000 $296,000
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $668,884 - $806,992
9,098 Added 245.63%
12,802 $1.09 Million
Q1 2019

May 14, 2019

SELL
$63.56 - $88.17 $3.55 Million - $4.93 Million
-55,874 Reduced 93.78%
3,704 $319,000
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $3.31 Million - $3.95 Million
56,532 Added 1855.94%
59,578 $3.78 Million
Q3 2018

Nov 14, 2018

SELL
$61.75 - $74.23 $2.21 Million - $2.66 Million
-35,790 Reduced 92.16%
3,046 $210,000
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $870,094 - $1.2 Million
14,299 Added 58.28%
38,836 $2.03 Million
Q1 2018

May 14, 2018

SELL
$83.06 - $100.98 $940,239 - $1.14 Million
-11,320 Reduced 31.57%
24,537 $2.05 Million
Q1 2018

May 14, 2018

BUY
$83.06 - $100.98 $2.04 Million - $2.48 Million
24,537 Added 216.76%
35,857 $3.12 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $590,176 - $735,512
-6,308 Reduced 35.78%
11,320 $1.07 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $1.92 Million - $2.44 Million
17,628
17,628 $2.06 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.